Kirste, S.; Rühle, A.; Zschiedrich, S.; Schultze-Seemann, W.; Jilg, C.A.; Neumann-Haefelin, E.; Lo, S.S.; Grosu, A.-L.; Kim, E.
Stereotactic Body Radiotherapy for Renal Cell Carcinoma in Patients with Von Hippel–Lindau Disease—Results of a Prospective Trial. Cancers 2022, 14, 5069.
https://doi.org/10.3390/cancers14205069
AMA Style
Kirste S, Rühle A, Zschiedrich S, Schultze-Seemann W, Jilg CA, Neumann-Haefelin E, Lo SS, Grosu A-L, Kim E.
Stereotactic Body Radiotherapy for Renal Cell Carcinoma in Patients with Von Hippel–Lindau Disease—Results of a Prospective Trial. Cancers. 2022; 14(20):5069.
https://doi.org/10.3390/cancers14205069
Chicago/Turabian Style
Kirste, Simon, Alexander Rühle, Stefan Zschiedrich, Wolfgang Schultze-Seemann, Cordula A. Jilg, Elke Neumann-Haefelin, Simon S. Lo, Anca-Ligia Grosu, and Emily Kim.
2022. "Stereotactic Body Radiotherapy for Renal Cell Carcinoma in Patients with Von Hippel–Lindau Disease—Results of a Prospective Trial" Cancers 14, no. 20: 5069.
https://doi.org/10.3390/cancers14205069
APA Style
Kirste, S., Rühle, A., Zschiedrich, S., Schultze-Seemann, W., Jilg, C. A., Neumann-Haefelin, E., Lo, S. S., Grosu, A.-L., & Kim, E.
(2022). Stereotactic Body Radiotherapy for Renal Cell Carcinoma in Patients with Von Hippel–Lindau Disease—Results of a Prospective Trial. Cancers, 14(20), 5069.
https://doi.org/10.3390/cancers14205069